Mezigdomide (MEZI) in novel-novel combinations for relapsed or refractory multiple myeloma (RRMM): Preliminary results from the CA057-003 trial Meeting Abstract
| Authors: | Costa, L. J.; Schjesvold, F.; Popat, R.; Siegel, D.; Usmani, S. Z.; Ali, S. A.; Chu, M. P.; Hartley-Brown, M. A.; Bahlis, N. J.; Oriol, A.; Lopez, J. M.; Ocio, E. M.; Ramasamy, K.; Reece, D.; Searle, E.; Gaudy, A.; Kurtova, A.; Zhang, W.; Sarmiento, R.; Dietrich, A.; Katz, J.; Pourdehnad, M.; Richardson, P. G. |
| Abstract Title: | Mezigdomide (MEZI) in novel-novel combinations for relapsed or refractory multiple myeloma (RRMM): Preliminary results from the CA057-003 trial |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 677 |
| End Page: | 679 |
| Language: | English |
| ACCESSION: | WOS:001415676400026 |
| DOI: | 10.1182/blood-2024-198403 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
